Molecular Imaging to Monitor Repair of Myocardial Infarction Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells.

Shi Shuo,Zhang Min,Guo Rui,Miao Ying,Zhang Xiangming,Li Biao
DOI: https://doi.org/10.2174/1566523215999150421164034
2015-01-01
Current Gene Therapy
Abstract:Heart tissue has a diminished ability to repair after myocardial infarction (MI). Bone marrow-derived mesenchymal stem cells (BMSCs) have been used effectively to heal damaged tissue after MI. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) can induce transcription of numerous pro-angiogenic genes and enhance stem cell survival. Here, we investigated whether HIF-1 alpha-transduced BMSCs could enhance tissue repair after MI, and compared the value of micro-PET/CT and echocardiography for evaluation of therapeutic effects. Rat BMSCs were transduced with a lentivirus expressing HIF-1 alpha and NIS (Lenti-HIF-1 alpha-NIS). Sodium iodide symporter (NIS) functioned as effective reporter gene, allowing monitoring of BMSCs transplanted into the rat heart for up to 2 weeks using micro-SPECT/CT imaging. In a rat MI model, after transplantation of HIF-1 alpha-NIS-transduced BMSCs to the MI zone, more expression of HIF-1 alpha, VEGF and Ang-4, more improvement of metabolism, less fibrotic tissue and cardiomyocyte apoptosis were detected in the MI zone. Moreover, we found that most of the transplanted HIF-1 alpha-NIS-transduced BMSCs differentiated into endothelial cells, and engineered new blood vessels in MI zone. Metabolic activity significantly increased at an early time point (2 weeks after transplantation) and lead to a sustained increase (4 weeks), as indicated by F-18-FDG uptake in micro-PET/CT imaging. Echocardiography indicated no improvement in cardiac function at 2 weeks and small improvement at 4 weeks. This study indicated that F-18-FDG micro-PET/CT was more useful for evaluating early therapeutic effects than echocardiography.
What problem does this paper attempt to address?